GSK Unit Gets Pfizer's Inhaler Patent Revoked At EPO
Pfizer's U.K. arm has lost its patent over a dry-powder inhaler after a GlaxoSmithKline unit convinced a European appeals panel that it isn't new, a ruling released Wednesday says....To view the full article, register now.
Already a subscriber? Click here to view full article